Saltar al contenido
Merck

The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.

Infection and immunity (2014-05-14)
Shannon N Moonah, Mayuresh M Abhyankar, Rashidul Haque, William A Petri
RESUMEN

The host inflammatory response contributes to the tissue damage that occurs during amebic colitis, with tumor necrosis factor alpha (TNF-α) being a key mediator of the gut inflammation observed. Mammalian macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that plays an important role in the exacerbation of a wide range of inflammatory diseases, including colitis. We identified a MIF gene homolog in the Entamoeba histolytica genome, raising the question of whether E. histolytica MIF (EhMIF) has proinflammatory activity similar to that of mammalian MIF. In this report, we describe the first functional characterization of EhMIF. Antibodies were prepared against recombinantly expressed EhMIF and used to demonstrate that EhMIF is expressed as a 12-kDa protein localized to the cytoplasm of trophozoites. In a manner similar to that of mammalian MIF, EhMIF interacted with the MIF receptor CD74 and bound to macrophages. EhMIF induced interleukin-6 (IL-6) production. In addition, EhMIF enhanced TNF-α secretion by amplifying TNF-α production by lipopolysaccharide (LPS)-stimulated macrophages and by inhibiting the glucocorticoid-mediated suppression of TNF-α secretion. EhMIF was expressed during human infection, as evidenced by the presence of anti-EhMIF antibodies in the sera of children living in an area where E. histolytica infection is endemic. Anti-EhMIF antibodies did not cross-react with human MIF. The ability of EhMIF to modulate host macrophage function may promote an exaggerated proinflammatory immune response and contribute to the tissue damage seen in amebic colitis.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Dexametasona, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
L-Glutatión reducido, suitable for cell culture, BioReagent, ≥98.0%, powder
Sigma-Aldrich
Dexametasona, ≥98% (HPLC), powder
Sigma-Aldrich
L-Glutatión reducido, ≥98.0%
Sigma-Aldrich
Dexametasona, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
Triton X-114, laboratory grade
USP
Dexametasona, United States Pharmacopeia (USP) Reference Standard
Supelco
L-Glutatión reducido, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Dexametasona, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Glutatión reducido, BioXtra, ≥98.0%
Sigma-Aldrich
Dexametasona, meets USP testing specifications
L-Glutatión reducido, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Dexametasona, tested according to Ph. Eur.
Dexametasona, European Pharmacopoeia (EP) Reference Standard
Supelco
Dexametasona, VETRANAL®, analytical standard
Dexametasona, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Octoclothepin maleate salt, solid
Dexametasona, European Pharmacopoeia (EP) Reference Standard
Dexametasona, British Pharmacopoeia (BP) Assay Standard